Detection of Epstein-Barr virus EBER sequence in post-transplant lymphoma patients with DNA dendrimers

Journal of Virological Methods

Volumn 77, Issue 2, 1999, Pages 153-163

  Orentas, Rimas J ^a   Rospkopf, Susan J ^a   Casper, James T ^a   Getts, Robert C ^b   Nilsen, Thor W ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Polyprobe Inc   (United States)

Author keywords

Dendrimer DNAs; Epstein Barr virus; HMV 4; Post transplant lymphoma; Viral detection; Viral load

Indexed keywords

DENDRIMER; RNA;

ARTICLE; CASE REPORT; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS DETECTION; VIRUS LOAD;

CELL LINE; DNA, VIRAL; EVALUATION STUDIES; GENETIC TECHNIQUES; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSPLANTATION; VIRAL LOAD; VIROLOGY;

HUMAN HERPESVIRUS 4;

EID: 0033042328     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00149-9     Document Type: Article

References (40)

1. Ambinder R.A., Lambe B.C., Mann R.B., Hayward S.D., Zehubauer B.A., Burns W.S., Charache P. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Mol. Cell. Probes. 4:1990;397-407.
2. Ambinder R.F., Mann R.B. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 145:1994;239-252.
3. Ambinder R.F., Orentas R.J., Robertson K.D. Epstein-Barr virus and Hodgkin's disease. Armitage J., Newland A., Keating A., Burnett A. Cambridge Medical Reviews. 1995;1-20 Cambridge University Press, Cambridge.
4. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Séguin C., Tufnell P.S., Barell B.G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
5. Bresers D., Cuypers H.T.M., Reesink H.W., user-Bunschoten E.P., van den Berg H.M., Schaasberg W.P., Wilber J.C., Urdea M.S., Neuwald P., Lelie P.N. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay from monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. J. Med. Virol. 43:1994;262-268.
6. Chen F., Zou J.-Z., Di Renzo L., Winberg G., Hu L.-F., Klien E., Klein G., Ernberg I. A subpopulation of normal B-cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP 1. J. Virol. 69:1995;3752-3758.
7. Decker L.L., Klaman L.D., Thorley-Lawson D.A. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70:1996;3286-3289.
8. Dewar R.L., Highbarger H.C., Sarmiento M.D., Todd J.A., Vasudevachari M.B., Davey R.T. Jr., Kovacs J.A., Salzman N.P., Lane H.C., Urdea M.S. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170:1994;1172-1179.
9. Gause W.C., Adamovicz J. Use of PCR to quantitate relative differences in gene expression. Dieffenbach C.W., Dveksler G.S. PCR Primer. 1995;293-311 Cold Spring Harbor Laboratory Press, Plainview, New York.
10. Hamilton-Dutoit S.J., Pallesen G. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology. 25:1994;101-111.
11. Heslop H.E., Ng C.Y.C., Li C., Smith C.A., Loftin S.K., Krance R.A., Brenner M.A., Rooney C.M. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:1996;551-555.
12. Horn T., Urdea M.S. Forks and combs and DNA: the synthesis of branched oligodeoxyoucleotides. Nucleic Acids Res. 17:1989;6959-6967.
13. Howe J.G., Steitz J.A. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc. Natl. Acad. Sci. USA. 83:1986;9006-9010.
14. Kelley P.K., McCain K.L. Respiratory contamination of polymerase chain reaction by human herpesvirus 6. Am. J. Hematol. 47:1994;325-327.
15. Kieff E. Epstein-Barr virus and its replication. Fields B.N., Knipe D.M., Howley P.M. Field Virology. 1996;2343-2396 Lippincott-Raven, Philadelphia.
16. Klein G., Svedmyr E., Jondal M., Persson P.O. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int. J. Cancer. 17:1976;21-26.
17. Lerner M.R., Andrews N.C., Miller G., Steitz J.A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 78:1981;805-809.
18. Lin J.-C., De B.K., Lin S.-C. Rapid and sensitive genotyping of Epstein-Barr virus using single-strand conformation polymorphism analysis of polymerase chain reaction products. J. Virol. Methods. 43:1993;233-246.
19. Lucas K.G., Burton R.L., Zimmerman S.E., Wang J., Cornetta K.G., Robertson K.A., Lee C.H., Lee C.H., Emanuel D.J. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood. 91:1998;3654-3661.
20. Martinez O.M., Villanueva J.C., Lawrence-Miyasaki L., Quinn M.B., Cox K., Krams S.M. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation. 59:1995;519-524.
21. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
22. Miyashita E.M., Yang B., Lam K.M.C., Crawford D.H., Thorley-Lawson D.A. A novel form of Epstein-Barr virus in normal B-cells in vivo. Cell. 80:1995;593-601.
23. Nilsen T.W., Grayzel J., Prensky W. Dendritic nucleic acid structures. J. Theor. Biol. 187:1997;273-284.
24. Orentas, 1998. Mol. Cell. Probes (accepted).
25. Pachl C., Todd J.A., Kern D.G., Sheridan P.J., Fong S.-J., Stempien M., Hoo B., Besemer D., Yeghiazarian T., Irvine B., Kolberg J., Kokka R., Nenwald P., Urdea M.S. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:1995;446-454.
26. Papadopoulos E.B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M.H., Castro-Malaspina H., Childs B.H., Gillio A.P., Small T.N., Young J.W., Kernan N.A., O'Reilly R.J. Infusion of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl. J. Med. 330:1994;1185-1191.
27. Razin E., Leslie K.B., Schrader J.W. Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. J. Immunol. 146:1997;981-987.
28. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia.
29. Riddler S.A., Breinig M.C., McKnight J.L.C. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 84:1994;972-984.
30. Rocchi G., de Felici A., Ragona G., Heinz A. Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. New Engl. J. Med. 296:1977;132-134.
31. Rooney C.M., Smith C.A., Ng C.Y.C., Loftin S., Li C., Krance R.A., Brenner M.K., Heslop H.E. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:1995;9-13.
32. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd:1989;Cold Spring Harbor Laboratory Press, New York.
33. Savoie A., Perpête C., Carpentier L., Joncas J., Alfieri C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood. 83:1994;2715-2722.
34. Schuster V., Ott G., Seidenspinner S., Kreth H.W. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood. 87(4):1996;1579-1585.
35. Svedmyr E., Ernberg I., Seely J., Weiland O., Masucci G., Tsukuda K., Szigeti R., Masucci M.G., Blomgren H., Berthold W., Henle W., Klein G. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin. Immunol. Immunopathol. 30:1984;437-450.
36. Tsai S.-T., Jin Y.-T., Wu T.-C. Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells. J. Virol. Methods. 54:1995;67-74.
37. Urdea M.S., Horn T., Fultz T.J., Anderson M., Running J.A., Hamren S., Ahle D., Chang C. Branched DNA amplification for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res. Symp. Ser. 24:1991;197-200.
38. Vogelbacker H.H., Getts R.C., Tian N., Labaczewski R., Nilsen T.W. DNA dendrimers: assembly and signal amplification. Proceedings of the American Chemical Society, Division of Polymeric Sciences: Science and Engineering, Spring Meeting. 76:1997;458-460.
39. Wetmur J.G., Davidson N. Kinetics of renaturation of DNA. J. Mol. Biol. 31:1968;349-370.
40. Yao Q.Y., Rickinson A.B., Epstein M.A. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer. 35:1985;35-42.